Trial Profile
Bromocriptine Quick Release (QR) as Adjunct Therapy in Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Bromocriptine (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 16 Jun 2020 Results (n=84) presented at the 80th Annual Scientific Sessions of the American Diabetes Association.
- 13 Jun 2019 Status changed from recruiting to completed.
- 24 Apr 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.